Patent Brew-Up: Investigating Beverage Gadgets
Published Date: 2/27/2026
Notice
Summary
Adrian Rivera Maynez Enterprises is asking the U.S. International Trade Commission to investigate certain beverage brewing products that might be breaking their patents. If the investigation agrees, some products could be blocked from being sold or imported into the U.S., which could shake up the market soon. This means companies selling these products should watch out for possible legal changes and restrictions starting in 2026.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
Imports and Sales Could Be Blocked
A company filed a complaint on January 23, 2026 (amended February 3, 2026), and the U.S. International Trade Commission instituted an investigation on February 24, 2026 into alleged infringement of U.S. Patent Nos. 12,396,588; 11,737,597; and 10,865,039 for "beverage brewing capsules and filters for single-serve beverage brewers." The complainant asks the Commission to issue a limited exclusion order and a cease and desist order, which could block the importation into the U.S. or the sale within the U.S. of the accused products if the Commission so finds.
Named Respondent Must Respond or Risk Default
The notice names Denys Orlov d/b/a GoodCups as the respondent and requires responses to the amended complaint and notice of investigation to be submitted in accordance with the Commission's rules within 20 days after the date of service. If the respondent does not file a timely response, the Commission may treat that as a waiver and enter determinations that could lead to an exclusion order or cease and desist order without further notice.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16811, Certain Ink Cartridges and Components Thereof II; Notice of a Commission Determination Finding a Violation Under Section 337; Issuance of a General Exclusion Order and Cease and Desist Orders; Termination of the Investigation
Notice is hereby given that the U.S. International Trade Commission has determined to find a violation under section 337 of the Tariff Act of 1930, as amended, and to issue a general exclusion order ("GEO") prohibiting the importation of products that infringe claims 1 and 7 of each of the following patents: U.S. Patent Nos. 8,764,172 ("the '172 patent"); 9,370,934 ("the '934 patent"); 11,535,038 ("the '038 patent"); 12,240,248 ("the '248 patent"); and 12,240,249 ("the '249 patent"); and cease and desist orders ("CDOs") against respondents Mountain Peak, Inc. and Straightouttaink, LP. The investigation is terminated.
2026-16816, Hand Trucks and Certain Parts Thereof From China; Determination
2026-16581, Carbazole Violet Pigment 23 From China and India; Termination of Five-Year Reviews
The Commission instituted the subject five-year reviews on May 1, 2026 to determine whether revocation of the countervailing duty order on carbazole violet pigment 23 from India and the antidumping duty orders on carbazole violet pigment 23 from China and India would be likely to lead to continuation or recurrence of material injury. On August 7, 2026, the Department of Commerce published notice in the Federal Register that it was revoking the orders applicable August 7, 2026, because no domestic interested party filed a timely notice of intent to participate. Accordingly, the subject reviews are terminated.
2026-16667, Certain Mobile Electronic Devices; Notice of Institution of Investigation
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on July 10, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Maxell, Ltd. of Kyoto, Japan. An amended complaint was filed on July 24, 2026. The amended complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain mobile electronic devices by reason of the infringement of certain claims of U.S. Patent No. 10,812,646 ("the '646 patent"); U.S. Patent No. 12,513,408 ("the '408 patent"); U.S. Patent No. 12,061,760 ("the '760 patent"); U.S. Patent No. 12,418,692 ("the '692 patent"); U.S. Patent No. 12,185,211 ("the '211 patent"); and U.S. Patent No. 12,647,935 ("the '935 patent"). The amended complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The amended complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
2026-16469, Choline Salts From China; Determinations
The U.S. International Trade Commission found that imports of choline salts from China might be hurting American businesses by being sold unfairly cheap and getting government help. This means a deeper investigation is starting soon, which could lead to new rules or tariffs to protect U.S. companies. If you’re involved in this industry, keep an eye out for updates and possible changes that could affect prices and trade.
2026-16302, Large Vertical Shaft Engines From China; Determinations
Previous / Next Documents
Previous: 2026-03922, New Postal Products
The Postal Service has asked for approval of new or changed special deals for some of its competitive mail products. This affects businesses and customers who use these services, with a chance to comment by March 3, 2026. These updates could mean new options or prices, so keep an eye out if you send or receive competitive mail products!
Next: 2026-03925, Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZYCUBO (Copper Histidinate)
The FDA just gave Sentynl Therapeutics a special priority review voucher for their new rare pediatric disease drug, ZYCUBO, which treats Menkes disease in kids. This voucher speeds up future FDA reviews, helping get important medicines to patients faster. The approval happened on January 12, 2026, and this voucher could also be sold or used to speed up other drug reviews, potentially saving time and money.